Related Experiment Videos
Neonatal intractable atrial flutter successfully treated with intravenous flecainide
1Department of Pediatrics, Dokkyo University School of Medicine, 880, Kitakobayashi, Mibu, Shimotsuga-gun, Tochigi 321-0293, Japan.
Pediatric Cardiology
|December 19, 2003
Summary
Intractable neonatal atrial flutter resistant to standard treatments was successfully managed with intravenous flecainide. This case highlights flecainide
Area of Science:
- Neonatal Cardiology
- Pediatric Electrophysiology
- Pharmacology
Background:
- Atrial flutter is a rare but serious condition in neonates.
- Standard treatments like digitalization and electrical cardioversion can be ineffective.
Observation:
- A neonate presented with intractable atrial flutter.
- The condition did not respond to digitalization or electrical cardioversion.
Findings:
- Intravenous flecainide administration completely resolved the atrial flutter.
- No proarrhythmic effects were observed following flecainide treatment.
Implications:
- Intravenous flecainide may be a viable treatment option for neonatal atrial flutter, even in refractory cases.
- This contrasts with its generally lower efficacy in older children, suggesting a potential role in neonatal care.